[go: up one dir, main page]

ZA957649B - Process for manufacture of a modified collagen-induced platelet aggregation inhibitor pallidipin - Google Patents

Process for manufacture of a modified collagen-induced platelet aggregation inhibitor pallidipin

Info

Publication number
ZA957649B
ZA957649B ZA957649A ZA957649A ZA957649B ZA 957649 B ZA957649 B ZA 957649B ZA 957649 A ZA957649 A ZA 957649A ZA 957649 A ZA957649 A ZA 957649A ZA 957649 B ZA957649 B ZA 957649B
Authority
ZA
South Africa
Prior art keywords
pallidipin
manufacture
platelet aggregation
aggregation inhibitor
induced platelet
Prior art date
Application number
ZA957649A
Other languages
English (en)
Inventor
Christiane Dr Noeske-Jungblut
Andreas Dr Becker
Bernard Dr Haendler
Original Assignee
Schering Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Schering Ag filed Critical Schering Ag
Publication of ZA957649B publication Critical patent/ZA957649B/xx

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K14/00Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00Antineoplastic agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00Drugs for disorders of the blood or the extracellular fluid
    • A61P7/02Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • A61P9/10Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00Medicinal preparations containing peptides
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K2319/00Fusion polypeptide
    • C07K2319/01Fusion polypeptide containing a localisation/targetting motif
    • C07K2319/02Fusion polypeptide containing a localisation/targetting motif containing a signal sequence

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • General Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Engineering & Computer Science (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biophysics (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Molecular Biology (AREA)
  • Genetics & Genomics (AREA)
  • Biochemistry (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Toxicology (AREA)
  • Zoology (AREA)
  • Hematology (AREA)
  • Diabetes (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Cardiology (AREA)
  • Vascular Medicine (AREA)
  • Urology & Nephrology (AREA)
  • Peptides Or Proteins (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
ZA957649A 1994-09-12 1995-09-12 Process for manufacture of a modified collagen-induced platelet aggregation inhibitor pallidipin ZA957649B (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
EP94250224 1994-09-12

Publications (1)

Publication Number Publication Date
ZA957649B true ZA957649B (en) 1996-04-15

Family

ID=8217517

Family Applications (1)

Application Number Title Priority Date Filing Date
ZA957649A ZA957649B (en) 1994-09-12 1995-09-12 Process for manufacture of a modified collagen-induced platelet aggregation inhibitor pallidipin

Country Status (22)

Country Link
US (1) US5882887A (xx)
EP (1) EP0781334A1 (xx)
JP (1) JPH10505502A (xx)
CN (1) CN1075836C (xx)
AU (1) AU701643B2 (xx)
BG (1) BG63276B1 (xx)
BR (1) BR9508910A (xx)
CA (1) CA2199719A1 (xx)
CZ (1) CZ76297A3 (xx)
FI (1) FI971013A0 (xx)
HU (1) HU222398B1 (xx)
IL (1) IL115272A0 (xx)
MX (1) MX9701720A (xx)
NO (1) NO971110L (xx)
NZ (1) NZ293261A (xx)
PL (1) PL184617B1 (xx)
RO (1) RO117971B1 (xx)
RU (1) RU2186110C2 (xx)
SI (1) SI9520093A (xx)
SK (1) SK29297A3 (xx)
WO (1) WO1996008563A1 (xx)
ZA (1) ZA957649B (xx)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU767172B2 (en) * 1999-03-18 2003-11-06 Merck Patent Gmbh Protein for blocking platelet adhesion
AU2005321315A1 (en) * 2004-12-28 2006-07-06 Ares Trading S.A. Compositions and methods for treating schizophrenia and related disorders
JP2009510105A (ja) * 2005-09-28 2009-03-12 バイオバスキュラー インコーポレーティッド 血小板および細胞の接着、細胞移動、および炎症を阻止するための方法および組成物
US20110034396A1 (en) * 2005-09-28 2011-02-10 Biovascular, Inc. Methods and compositions for inhibiting cell migration and treatment of inflammatory conditions
TWI391143B (zh) 2005-11-04 2013-04-01 Otsuka Pharma Co Ltd 血小板凝集抑制劑組成物
US9617302B2 (en) * 2011-06-14 2017-04-11 National Taiwan University Peptide compounds for inhibition of platelet aggregation
FR2979346B1 (fr) 2011-08-23 2013-09-27 Univ Joseph Fourier Nanocorps anti-vcam-1
CN107982548A (zh) 2012-02-07 2018-05-04 全球生物疗法有限公司 核酸输送的区室化方法及其组合物和应用
ES2797625T3 (es) 2012-09-07 2020-12-03 Inst Nat Sante Rech Med Péptidos inhibitorios derivados del receptor desencadenante expresado en células mieloides-1 (TREM-1) y del transcrito similar a TREM 1 (TLT-1) y sus usos
US11364032B2 (en) 2013-08-08 2022-06-21 Global Bio Therapeutics, Inc. Clamp device for minimally invasive procedures and uses thereof
FR3058143B1 (fr) 2016-10-27 2021-03-12 Univ Grenoble Alpes Nanocorps anti-tau
EP4340855A1 (en) 2021-08-13 2024-03-27 Triovance Holding LLC A skin substitute composition and methods of producing and using the same

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH03503596A (ja) * 1987-06-24 1991-08-15 ノボ・ノルディスク エー/エス 蛋白質若しくはポリペプチドの調製方法、該ポリペプチドをコードするdna配列、該dna配列およびポリペプチドを有する微生物および該ポリペプチドの薬学的製剤としての利用
US5756454A (en) * 1991-09-05 1998-05-26 Schering Aktiengesellschaft Collagen-induced platelet aggregation inhibitor
KR100232683B1 (ko) * 1991-09-05 1999-12-01 에바-마리아 시마-메이어 콜라겐에 의해 유도되는 혈소판 응집 억제제
US5705362A (en) * 1992-05-25 1998-01-06 Gist-Brocades, N.V. Modified signal sequences

Also Published As

Publication number Publication date
CN1159828A (zh) 1997-09-17
SK29297A3 (en) 1997-10-08
FI971013A7 (fi) 1997-03-11
HU222398B1 (hu) 2003-06-28
BR9508910A (pt) 1997-10-28
RO117971B1 (ro) 2002-11-29
SI9520093A (en) 1997-08-31
NZ293261A (en) 1998-11-25
AU701643B2 (en) 1999-02-04
PL184617B1 (pl) 2002-11-29
AU3565795A (en) 1996-03-29
JPH10505502A (ja) 1998-06-02
PL319078A1 (en) 1997-07-21
CA2199719A1 (en) 1996-03-21
NO971110L (no) 1997-05-07
NO971110D0 (no) 1997-03-11
BG101226A (bg) 1998-10-30
CZ76297A3 (cs) 1998-01-14
EP0781334A1 (en) 1997-07-02
WO1996008563A1 (en) 1996-03-21
MX9701720A (es) 1997-06-28
IL115272A0 (en) 1995-12-31
BG63276B1 (bg) 2001-08-31
HUT76972A (hu) 1998-01-28
FI971013A0 (fi) 1997-03-11
CN1075836C (zh) 2001-12-05
US5882887A (en) 1999-03-16
RU2186110C2 (ru) 2002-07-27

Similar Documents

Publication Publication Date Title
GB9423332D0 (en) Method of making a library of compounds
IL122814A0 (en) Inhibitors of platelet aggregation
ZA957649B (en) Process for manufacture of a modified collagen-induced platelet aggregation inhibitor pallidipin
EP0715908A3 (en) Process for producing a cup-shaped part
GR3030456T3 (en) Process for the manufacture of n-phosphonomethylglycine
IL116143A0 (en) Production of a siliceous refractory mass
EP0707034A3 (en) Process for the production of foamed material
ZA954204B (en) A process for improving the effectiveness of a process catalyst
SG47817A1 (en) Organsulfur compounds a process for their production and their use
IL112707A0 (en) Process for the manufacture of a ceramic part
HUP9901261A3 (en) Process for the manufacture of a colour-marked object
AU681215B2 (en) A process for the purification of fullerenes
GB9622712D0 (en) Process for the manufacture of a packaging blank
GB2296722B (en) Method of producing a flexible absorbent article
GB9401911D0 (en) A method of discriminating an article
SG50583A1 (en) Process for manufacture of a zeolite
IL115848A0 (en) Production of triazoles
GB9821822D0 (en) Process for the manufacture of a product
GB9406432D0 (en) Process for the manufacture of a zeolite
IL108824A0 (en) A process for the acylation of ferrocene
IL117651A0 (en) Process for the manufacture of a polyolefin shaped article
HUT51628A (en) A new process for producing macrolidous compounds having antibiotical effect
KR0108496Y1 (en) Evaporator of a cooling machine
ZA965905B (en) New inhibitors of platelet aggregation
IL110424A0 (en) A process for purification of used oils